Flash Alert – ORA & TTI Report – 5.9.12
09
May 12
Ormat Technologies (ORA) reported after the close last night and held their conference call this morning. It was a good quarter and the stock traded as high as $22, up nearly 15%, this morning. They blew the roof off of Wall Street’s forecast for $110.6 million in revenues and five cents a share, and guided for 2012 results above the consensus. ORA reported a record quarter of $132.4 million in revenues, up 35.3% from last year. The electricity segment did $82.2 million versus $78.2 million last year. The product segment more than doubled to $50.1 million versus $19.6 million last...
May 12
Flash Alert – SeekingAlpha Article on Arena – 5.4.12
04
May 12
Dear New World Investor: I will submit this article to SeekingAlpha today. It should be on their webiste this weekend, and will be picked up by Yahoo Finance on Monday. I am also submitting it as a public comment to the Advisory Committee meeting on May 10. What Arena Pharmaceuticals Needs To Say To The May 10 FDA Advisory Committee Arena Pharmaceuticals will go before their second FDA Advisory Committee on May 10, seeking approval of lorcaserin for the treatment of obesity. Their PDUFA date for a final FDA decision is June 27. Recently, the FDA delayed the PDUFA date...
May 12
Get a Free Trial Today
Don't miss out on each week's high-performing stock opportunities. Are you going to get in the game, or stay on the sidelines?
